Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and cisplatin in recurrent or metastatic esophageal cancer
NCT01444547Phase 2Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jan 2007
- Primary completion
- Dec 2015
- Modality
- Nanoparticles, Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, Cisplatin micelle injection (HA132) in esophageal cancer, sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
Paclitaxel Micelles for InjectionCisplatin micelle injection (HA132)
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT01444547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01444547.